Argon laser trabeculoplasty and reduction of ocular hypotensive medication used by glaucoma patients

Canadian Journal of Ophthalmology

Volumn 41, Issue 1, 2006, Pages 44-50

  Vaidergorn, Paul Gelman ^a,b   Susanna Jr , Remo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Compliance; Glaucoma; Laser trabeculoplasty

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARGON LASER; ARTICLE; CHRONIC DISEASE; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; TRABECULOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 33645119746     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(06)80066-9     Document Type: Article

References (20)

1. Bankes JLK, Perkins ES, Tsolakis S, Wright JE, Singh K. Bedford glaucoma survey. BMJ 1968;30:791-6.
2. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996;80:389-93.
3. Sommer A, Tielsh JM, Katz J, et al. Relationship between intraocular pressure and primary open-angle glaucoma among white and black patients. Baltimore eye survey. Arch Ophthalmol 1991;109:1090-5.
4. Thomas JV, Simmons RJ, Belcher CD. Argon laser trabeculoplasty in the presurgical glaucoma patient. Ophthalmology 1992;89:187-97.
5. Schwartz AL, Whitten ME, Bleiman B, Martin D. Argon laser trabecular surgery in uncontrolled phakic open angle glaucoma. Ophthalmology 1981;88:203-12.
6. Horns DJ, Bellows AR, Hutchinson BT, Allen RC. Argon laser trabeculoplasty for open angle glaucoma. A retrospective study of 380 eyes. Trans Ophthalmol Soc U K 1983;103: 288-95.
7. Lieberman MF, Hoskins HD, Hetherington J Jr. Laser trabeculoplasty and the glaucomas. Ophthalmology 1983;90: 790-5.
8. Reiss GR, Wilensky JT, Higginbotham EJ. Laser trabeculoplasty. Surv Ophthalmol 1991;35:407-28.
9. Wilensky JT. Laser trabeculoplasty. Section III. In: Kaufman PL, Mittag TW, eds. Textbook of Ophthalmology. London: Mosby; 1994:936-7.
10. Susanna R Jr, Takahashi W, Betinjane A. Reproductibility of the diurnal tension curve on consecutive days. Arq Bras Oftalmol 1979;42:275-6.
11. Drance SM. The significance of diurnal tension variations in normal and glaucomatous eyes. Arch Ophthalmol 1960;64: 494-501.
12. The Glaucoma Laser Trial (GLT). Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology 1990; 97:1403-12.
13. Krupin T, Patkin R, Kurata FK, et al. Argon laser trabeculoplasty in black and white patients with primary open angle glaucoma. Ophthalmology 1986;93:811-6.
14. Eguchi S, Yamashita H, Yamamoyo T, Shirato S, Kitazawa Y. Methods of argon laser trabeculoplasty, complications and long-term follow-up of the results. Jpn J Ophthalmol 1985; 29:198-202.
15. Schwartz AL, Love DC, Schwartz MA. Long-term follow-up of argon laser trabeculoplasty for uncontrolled open angle glaucoma. Arch Ophthalmol 1985;103:1482-7.
16. Pollack IP, Robin AL, Sax H. The effect of argon laser trabeculoplasty on medical control of primary open angle glaucoma. Ophthalmology 1983;90:785-90.
17. Winfield AJ, Jessiman D, Williams A, Esakowicz L. A study of the causes of noncompliance by patients prescribed eye-drops. Br J Ophthalmol 1990;74:77-83.
18. Van Buskirk EM. The compliance factor. Am J Ophthalmol 1986;101:609.
19. Worthen A. Economic aspects of the management of ocular hypertension. Surv Ophthalmol 1980;25:206-12.
20. Amaral JMF, Moreira RAR, Silva LS, et al. Monthly cost of glaucoma medications in Brazil. Arq Bras Oftalmol 1999;62: 123-6.